RE:Use of proceeds Considering we were repeatedly told that the company would not do a financing that was shareholder unfriendly it' just goes to show you can't believe what they say when they don't lay out exactly why they are doing this. It's utterly shocking.
palinc2000 wrote: It has to be a mix of the following::
Acquisition of an already commercialized drug and the balance as a buffer to increase working capital so they dont have to access any more funds from Marathon